• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    DCAT Week ’19

    Temperature-Controlled Logistics

    Reducing Pill Burden

    Nasal Drug Delivery

    AI in Pharma: Transforming Data into Drugs
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    BASi Appoints COO

    Nestlé Health Licenses Codexis’ CDX-6114

    SK, Arvelle Sign $530M Deal for Antiepileptic Drug

    GS1 Delivers Lightweight Messaging Standard For Verification of Product Identifiers

    Progenics Launches Mfg. Ops in NJ
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Progenics Launches Mfg. Ops in NJ

    Pelican BioThermal Opens New Network Location

    Reed-Lane Facility Tour

    Haselmeier Acquires Drug Manufacturing License

    Emerald Health, Lonza Enter Large-Scale Mfg. Pact
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    GS1 Delivers Lightweight Messaging Standard For Verification of Product Identifiers

    Pelican BioThermal Opens New Network Location

    Reed-Lane Facility Tour

    Recipharm Facilities Ready for EU Serialization

    Andrew Alliance, Sartorius Launch Research Solution
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Nestlé Health Licenses Codexis’ CDX-6114

    Personalized Medicine: Getting More Out of Clinical Trials

    SK, Arvelle Sign $530M Deal for Antiepileptic Drug

    Charles River to Pay $510M for Citoxlab

    West, Swissfillon Enter Drug Delivery Partnership
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Former FDA Senior Executives Join PAREXEL

    Top Global Pharma Company to Implement ValGenesis' VLMS

    WCG, Prudentia Enter Pharmacovigilance Alliance

    ValGenesis VLMS Chosen to Digitize Validation Process

    Serialization Compliance: Understanding the Challenges
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Ajinomoto Bio-Pharma Services

    Alcami

    Ascendia Pharmaceuticals

    Baxter BioPharma Solutions

    Reed-Lane, Inc.
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Baxter BioPharma Solutions

    Ajinomoto Bio-Pharma Services

    Jubilant HollisterStier Contract Manufacturing & Services

    Federal Equipment Company

    Reed-Lane, Inc.
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
      • Top 20 Pharma & BioPharma
      • Top 10 BioPharma Companies
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Agenda
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Features

    DCAT WEEK ’18 A Unique Model That Drives Value

    Highly anticipated DCAT Week ’18 returns to New York City March 19 – 22

    The 92nd DCAT Annual Dinner will feature speaker Will Smith. As an actor, producer, and musician, two-time Academy Award nominee and Grammy Award Winner, Will Smith has enjoyed a diverse career encompassing films, television, and multi-platinum records.
    The 92nd DCAT Annual Dinner will feature speaker Will Smith. As an actor, producer, and musician, two-time Academy Award nominee and Grammy Award Winner, Will Smith has enjoyed a diverse career encompassing films, television, and multi-platinum records.
    Related CONTENT
    • Boehringer, Gubra in $250M Obesity Collaboration
    • Boehringer, TARGET Pharma in Strategic NASH Pact
    • EMD Serono Appoints Market Access SVP
    • Astellas Appoints Specialty, Medical Affairs VP
    • DCAT Elects President
    01.30.18
    DCAT Week is unlike any other event on the industry calendar. DCAT Week offers companies the opportunity to host private meetings with customers, suppliers and potential business partners in their reserved Business Meeting Space across eight Official DCAT Week Hotels. Although those meetings are mostly pre-scheduled, DCAT Week’s activities and events offer additional opportunities for introductions, impromptu meetings and other business connections. The majority of DCAT Week attendees (92%) are high-level decision makers, with one in four attendees being C-Suite executives.

    DCAT Week is hosted and organized by the Drug, Chemical & Associated Technologies Association (DCAT), a not-for-profit, member-supported, global business development association, composed of more than 400 corporate members that includes innovator and generic drug companies and suppliers of ingredients, development and manufacturing services, and related technologies.

    New for DCAT Week ’18, the InterContinental Barclay Hotel will serve as the official hub of the week’s activities. With full access to the hotel’s facilities and staff, the DCAT organization will offer additional benefits to its member companies, including high-profile branding opportunities and a larger block of sleeping rooms at discounted rates.
    In addition to providing its members with a forum for high-level strategic meetings with key decision makers, DCAT Week offers networking events and education programs to help DCAT members expand their business network and stay informed on industry trends, analysis and best practices. 

    DCAT Week kicks off on Monday, March 19th with the Member Company Announcement Forum, an important platform for DCAT member companies to make major news announcements on strategy developments, mergers and acquisitions (M&A), post-M&A integration, and significant manufacturing expansion activity in front of the industry press and standing-room only crowds.

    DCAT Week ’18: Building Relationships
    DCAT Week offers a variety of opportunities for members to expand their network of customers, suppliers and colleagues through a variety of networking events.
    The Comedy Club & Networking Event on Monday, March 19th gives attendees the opportunity to network and enjoy one of New York City’s top comedians, all while supporting STEM education. Proceeds from the event support DCAT’s scholarship initiatives, which benefit high school students across the globe who are interested in pursuing a career in science.

    DCAT Week would not be possible without the support and leadership of DCAT member companies and their representatives. A Volunteer Recognition Luncheon will thank and recognize the over 100 volunteers who serve on the organization’s Board of Directors, Advisory Council, Standing Committees and Task Forces that developed the programs, events and services provided to member companies throughout the year.

    After a busy day of meetings, member representatives look forward to the DCAT Member Company Reception on Tuesday, March 20th before heading out to their customer dinners. With over 700 member representatives in attendance, this networking reception is one of the largest gatherings of the week.

    Thursday’s DCAT Women’s Networking Breakfast will feature a presentation by Shari Harley, founder and president of Candid Culture, a leadership and business communication consulting firm, and author of “How to Say Anything to Anyone: A Guide to Building Business Relationships that Really Work.” Her presentation will focus on how attendees can take charge of their careers by strengthening their business relationships through improved business-communication skills.

    The final networking event of the week is the 92nd DCAT Annual Dinner—a black-tie event not be missed. Over 2,000 DCAT members and their guests will gather on Thursday evening, March 22nd in the Grand Ballroom in the New York Hilton for this festive celebration, including a keynote address by actor, producer, musician and two-time Academy Award nominee and Grammy Award Winner, Will Smith.

    DCAT Week ’18: Industry Education with a Focus on Innovation
    Innovation drives the pharmaceutical industry, so how is innovation translating into overall pharmaceutical industry growth, advancing R&D productivity, and transforming manufacturing and supply management? The DCAT Week ’18 education programs, developed by the organization’s Education Committee and Task Forces, will address these issues during five education programs that will be held throughout the week. Each program includes a networking component.

    The popular Pharmaceutical Industry Outlook will examine pharmaceutical industry growth overall, the product mix between small molecules and biologics, and growth in developed and emerging markets. The program will also have an Executive Forum to gain further insights on the factors impacting industry performance.

    A new Executive Insights series will feature two programs with on-stage interviews with leading pharmaceutical executives to examine the macro issues impacting drug development and manufacturing. The first program will include executives from EMD Serono, Boehringer Ingelheim, and Roviant Sciences, who will offer views of the current and future direction of drug development and product innovation, including new business models for R&D, rising therapeutic areas, and the role of precision medicines. The second program, which will feature executives from AstraZenca, Celgene, and Vertex Pharmaceuticals, will cover the key drivers influencing biopharmaceutical, and pharmaceutical manufacturing and supply, including how technology and product mix are impacting demand and supply.

    The Innovation in Sourcing and Procurement program will offer best practices and lessons learned from leading executives in sourcing, procurement, and supply management on how to drive value and performance in the pharmaceutical customer–supplier relationship. Topics include: advanced sourcing in new product development; innovative approaches in project management and supplier metrics to successfully move manufacturing of a molecule from in-house to external production; and best practices in collaborative supply-chain planning.

    Another new program for DCAT Week ’18 is Emerging Pharma: Strategies for Optimizing Manufacturing and Supply, which will examine how emerging pharmaceutical companies can develop and implement the optimal manufacturing strategy for their drug candidates. The program will provide: insights on how drug pricing and the payer/reimbursement environment are impacting product development and commercialization, including how manufacturing and product-design choices can impact downstream pricing and coverage; best practices for the selection and management of CDMOs or CMOs; and manufacturing considerations in the due-diligence process when partnering with larger pharmaceutical companies. 

    For a complete schedule of programs and events, visit www.dcatweek.org. 
    Related Searches
    • biologics
    • expansion
    • business development
    • events
    Suggested For You
    The Past, Present and Future of Sourcing and Procurement The Past, Present and Future of Sourcing and Procurement
    BeiGene, Boehringer Ingelheim Enter Supply Agreement BeiGene, Boehringer Ingelheim Enter Supply Agreement
    Boehringer Ingelheim and Autifony Enter Agreement Boehringer Ingelheim and Autifony Enter Agreement
    HTG, Merck KGaA Expand Master Collaboration Agreement HTG, Merck KGaA Expand Master Collaboration Agreement
    Executive Moves at Shire Executive Moves at Shire
    HitGen, Boehringer Ingelheim Enter Drug Discovery Collaboration HitGen, Boehringer Ingelheim Enter Drug Discovery Collaboration
    The Past, Present and Future of Sourcing and Procurement The Past, Present and Future of Sourcing and Procurement
    DCAT Elects President DCAT Elects President
    Astellas Appoints Specialty, Medical Affairs VP Astellas Appoints Specialty, Medical Affairs VP
    EMD Serono Appoints Market Access SVP EMD Serono Appoints Market Access SVP
    Boehringer, TARGET Pharma in Strategic NASH Pact Boehringer, TARGET Pharma in Strategic NASH Pact
    Boehringer, Gubra in $250M Obesity Collaboration Boehringer, Gubra in $250M Obesity Collaboration

    Related Features

    • DCAT Week ’19

      DCAT Week ’19

      Where Business Gets Done
      01.25.19

    • Cold Chain Management
      Temperature-Controlled Logistics

      Temperature-Controlled Logistics

      Cryoport tackles market needs with new NJ facility
      Betsy Louda, Contract Pharma 01.25.19

    • Solid Dosage/Creams/Ointments
      Reducing Pill Burden

      Reducing Pill Burden

      Challenges and solutions for lowering the pill burden of amorphous spray dried dispersion drug products
      Deanna Mudie, Aaron Stewart, Stephanie Buchanan, Alyssa Ekdahl, Lonza Pharma & Biotech 01.25.19


    • Drug Delivery
      Nasal Drug Delivery

      Nasal Drug Delivery

      A look at best practices for testing nasal drug delivery devices
      Maria Smith, senior manager & Charles Shaw, scientific advisor, Renaissance Lakewood LLC 01.25.19

    • AI in Pharma: Transforming Data into Drugs

      AI in Pharma: Transforming Data into Drugs

      Jane Z. Reed of Linguamatics discusses the potential benefits and obstacles leveraging data through AI
      Kristin Brooks, Contract Pharma 01.25.19

    • Information Technology
      Digitization: Pharma 4.0

      Digitization: Pharma 4.0

      A look at how technology is impacting the pharma industry
      Fatih Kaya and Gerald Buerkle, Vetter Pharma 01.25.19


    • Regulatory Affairs | Serialization
      Serialization Compliance: Understanding the Challenges

      Serialization Compliance: Understanding the Challenges

      Pharmaceutical Industry Trails Behind on Serialization for DSCSA.
      Peter F. Sturtevant, Senior Director, Industry Engagement – Pharmaceuticals, GS1 US 01.25.19

    • Information Technology
      FDA & Data Integrity

      FDA & Data Integrity

      FDA Publishes Final Guidance on Data Integrity
      Robert Marohn, Director of Quality Business Systems, Kite Pharmaceutical 01.25.19

    • Facilities | Lyophilization
      Rising Demand for Lyophilized Products

      Rising Demand for Lyophilized Products

      Jubilant installs new oven to increase manufacturing capacity and keep up with biopharma’s growing need for lyophilization services
      Tim Wright, Contract Pharma 01.25.19


    • Drug Development
      Future Trends in the CDMO Space

      Future Trends in the CDMO Space

      And how to navigate them for successful drug development
      Guillaume Plane, Global Development and Marketing Manager, BioReliance End-to-End Solutions, MilliporeSigma 01.25.19

    • APIs | Cytotoxics and High Potency Manufacturing | Drug Development
      CDMOs On The Rise

      CDMOs On The Rise

      Tracking growth and strategies in the CDMO business
      Michel Le Bars, Managing Partner, Kurmann Partners AGe 01.25.19

    • APIs | Excipients
      Pharmaceutical Fine Chemicals Trends

      Pharmaceutical Fine Chemicals Trends

      Moving toward a new order in the pharmaceutical fine chemical / CD&M industry?
      Dr. Enrico T. Polastro, Vice President, Arthur D. Little Benelux SA/NV 11.13.18

    • Laboratory Testing
      Necessary, Appropriate, Valid: A mantra for facility managers creating complete health strategies

      Necessary, Appropriate, Valid: A mantra for facility managers creating complete health strategies

      The challenge of maintaining colony health; the importance of health monitoring
      Emmanuel Gomas, European Services Manager, Envigo 11.13.18

    • Drug Development | Formulation Development
      Abuse Deterrent Formulations

      Abuse Deterrent Formulations

      A look at opioid abuse in North America and formulations to help avoid an epidemic.
      Damon Smith, Richard Dart and Christopher Hirst 11.13.18

    • Bioanalytical Services
      Viral Contaminant Testing in Biopharma Manufacturing

      Viral Contaminant Testing in Biopharma Manufacturing

      There is no single test to detect all potential viral contaminants in biopharmaceutical manufacturing.
      Richard Adair, Virology Manager, SGS Life Sciences, Glasgow, UK 11.13.18

    Breaking News
    • BASi Appoints COO
    • Nestlé Health Licenses Codexis’ CDX-6114
    • SK, Arvelle Sign $530M Deal for Antiepileptic Drug
    • GS1 Delivers Lightweight Messaging Standard For Verification of Product Identifiers
    • Progenics Launches Mfg. Ops in NJ
    View Breaking News >
    CURRENT ISSUE

    January/February 2019

    • DCAT Week ’19
    • Temperature-Controlled Logistics
    • Reducing Pill Burden
    • Nasal Drug Delivery
    • AI in Pharma: Transforming Data into Drugs
    • Digitization: Pharma 4.0
    • Serialization Compliance: Understanding the Challenges
    • FDA & Data Integrity
    • Rising Demand for Lyophilized Products
    • Future Trends in the CDMO Space
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • privacy policy
    • term and condition
    • about us
    • contact us

    follow us

    Subscribe

    magazines

    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image

    Copyright © 2019 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login